Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

BioCorRx (BICX) FCF Margin (2016 - 2025)

BioCorRx's FCF Margin history spans 15 years, with the latest figure at 99.88% for Q3 2025.

  • For Q3 2025, FCF Margin changed N/A year-over-year to 99.88%; the TTM value through Sep 2025 reached 179.02%, up 501934.0%, while the annual FY2024 figure was 14302.07%, 1222347.0% down from the prior year.
  • FCF Margin for Q3 2025 was 99.88% at BioCorRx, down from 70.97% in the prior quarter.
  • Across five years, FCF Margin topped out at 70.97% in Q2 2025 and bottomed at 9383.09% in Q1 2024.
  • The 5-year median for FCF Margin is 2910.84% (2023), against an average of 3582.35%.
  • The largest annual shift saw FCF Margin plummeted -840056bps in 2024 before it surged 887188bps in 2025.
  • A 5-year view of FCF Margin shows it stood at 4757.39% in 2021, then skyrocketed by 89bps to 542.44% in 2022, then plummeted by -420bps to 2818.86% in 2023, then tumbled by -33bps to 3754.59% in 2024, then surged by 97bps to 99.88% in 2025.
  • Per Business Quant, the three most recent readings for BICX's FCF Margin are 99.88% (Q3 2025), 70.97% (Q2 2025), and 511.21% (Q1 2025).